fda glp-1 warning news november 2025 The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. https://www.abc27.com/national/compounded-glp-1 -drugs-creating-concern-among-doctors-and-fda/?utm_medium FDA issued 25 warning letters

Glucagon-like peptide-1 (GLP-1) in the integration of neural and endocrine responses to stress

As the efficacy of insulin may be modulated by several factors including ApoE genotype and sex, targeted treatment may be necessary

Effect of incretin-based therapies on blood pressure: a systematic review and meta-analysis (European Journal of Preventive Cardiology)

The implications of this simple experiment are profound: cells in the small intestine can secrete factors (named hormones in 1905) that regulate pancreatic function and glucose metabolism

Some more than others experience structural barriers to food, nutrition and lifestyle skills

Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC